戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t insertion for the management of descending thoracic aortic aneurysm.
2 bruary 1996, we operated on 512 patients for thoracic aortic aneurysm.
3 condition, which is commonly associated with thoracic aortic aneurysm.
4  mortality during the resection of ascending thoracic aortic aneurysms.
5 at underwent elective surgery for descending thoracic aortic aneurysms.
6 ase PWS in finite element analysis models of thoracic aortic aneurysms.
7 WS) in finite element analysis of descending thoracic aortic aneurysms.
8 ceptors in AngII-induced atherosclerosis and thoracic aortic aneurysms.
9  repair for many patients with abdominal and thoracic aortic aneurysms.
10 emodeling and intimal expansion of ascending thoracic aortic aneurysms.
11 om loss of VSMCs occurs in primary ascending thoracic aortic aneurysms.
12 e contained 1010 patients: 670 patients with thoracic aortic aneurysm, 195 with chronic type B aortic
13 .2, and 0.4 deaths per 100 patient-years for thoracic aortic aneurysm, acute type B aortic dissection
14 .9, and 3.2 deaths per 100 patient-years for thoracic aortic aneurysm, acute type B aortic dissection
15  smooth muscle isoform of alpha-actin, cause thoracic aortic aneurysms, acute aortic dissections, and
16                                              Thoracic aortic aneurysm affecting the arch and proximal
17 iscusses published data on genes involved in thoracic aortic aneurysm and attempts to explain diverge
18                                              Thoracic aortic aneurysm and dissection (TAAD) is an aut
19 ing pathology observed in heritable forms of thoracic aortic aneurysm and dissection (TAAD).
20  however, excess TGF-beta signaling promotes thoracic aortic aneurysm and dissection in multiple diso
21  been identified to cause autosomal dominant thoracic aortic aneurysm and dissection.
22  muscle actin, have been identified to cause thoracic aortic aneurysm and dissection.
23 that individual mechanisms may contribute to thoracic aortic aneurysm and dissection.
24 pression in aortic tissue from patients with thoracic aortic aneurysm and found increased S100A12 exp
25 al controversies and uncertainties regarding thoracic aortic aneurysm and its treatment.
26 y feasible method for treatment of traumatic thoracic aortic aneurysm and may be an effective alterna
27                                              Thoracic aortic aneurysms and acute aortic dissections (
28 ficiency does not affect AngII-induced AAAs, thoracic aortic aneurysms and atherosclerosis.
29 lood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions)
30 al registry of GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions)
31 n of all patients with clinically recognized thoracic aortic aneurysms and constitute the majority of
32 lies identified with dominant inheritance of thoracic aortic aneurysms and dissections (TAA/dissectio
33 most common genetic alterations for familial thoracic aortic aneurysms and dissections (TAAD) are mis
34                                     Although thoracic aortic aneurysms and dissections (TAAD) can be
35                                              Thoracic aortic aneurysms and dissections (TAAD) cause s
36                                     Familial thoracic aortic aneurysms and dissections (TAAD) occur a
37                                              Thoracic aortic aneurysms and dissections (TAAD) represe
38  Heterozygous ACTA2 mutations cause familial thoracic aortic aneurysms and dissections (TAAD), but on
39                                    Heritable thoracic aortic aneurysms and dissections (TAAD), includ
40 A2, are the most prevalent cause of familial thoracic aortic aneurysms and dissections (TAAD).
41 e responsible for 14% of inherited ascending thoracic aortic aneurysms and dissections (TAAD).
42                                Non-syndromic thoracic aortic aneurysms and dissections (TAADs) are in
43 ic isoform of alpha-actin (alpha-SMA), cause thoracic aortic aneurysms and dissections and occlusive
44                                              Thoracic aortic aneurysms and dissections are associated
45 es for the medical and surgical treatment of thoracic aortic aneurysms and dissections are becoming i
46  Marfan syndrome, that predispose persons to thoracic aortic aneurysms and dissections are understood
47  genetic contribution to the pathogenesis of thoracic aortic aneurysms and dissections has revealed p
48 hat these variants predispose individuals to thoracic aortic aneurysms and dissections includes the f
49                   First, the pathogenesis of thoracic aortic aneurysms and dissections is better unde
50 ominant non-syndromic hearing loss, familial thoracic aortic aneurysms and dissections, and multiple
51  patients with conditions that predispose to thoracic aortic aneurysms and dissections, including MFS
52 esponsible for 25% of families with familial thoracic aortic aneurysms and dissections.
53 mutation responsible for a large family with thoracic aortic aneurysms and dissections.
54 could lead to new therapeutic strategies for thoracic aortic aneurysms and dissections.
55                  This review focuses only on thoracic aortic aneurysms and dissections.
56 ooth-muscle cells (SMCs) can cause inherited thoracic aortic aneurysms and dissections.
57                 S100A12 is enriched in human thoracic aortic aneurysms and dissections.
58  SNPs at the FBN1 locus associated with both thoracic aortic aneurysms and dissections.
59 the relevance of S100A12 expression to human thoracic aortic aneurysms and type A thoracic aortic ane
60 eases affecting the ascending aorta, such as thoracic aortic aneurysms and type I and II dissections,
61 ity is high in the midterm for patients with thoracic aortic aneurysm, and managing modifiable risk f
62 he variability of penetrance of both BAV and thoracic aortic aneurysm as well as the variability of t
63 ts contribute to the initiation of ascending thoracic aortic aneurysms (ATAAs) in patients with bicus
64 n syndrome (MFS) is known to cause ascending thoracic aortic aneurysms (ATAAs).
65               Repair of thoracoabdominal and thoracic aortic aneurysm by the traditional clamp-and-go
66 t-to-treat complications in the treatment of thoracic aortic aneurysms by endovascular stent-grafting
67 nd in approximately 25% of clinically stable thoracic aortic aneurysm cases.
68 e is remarkably similar to a subset of human thoracic aortic aneurysms caused by mutations in SMC con
69 ents undergoing elective surgical repair for thoracic aortic aneurysm, despite similar preoperative r
70 0A12 protein expressed in all cases of acute thoracic aortic aneurysm dissection and in approximately
71 o human thoracic aortic aneurysms and type A thoracic aortic aneurysm dissection and to study mechani
72 ts who underwent repair of chronic ascending thoracic aortic aneurysms from 1986 to present.
73 se models and the discovery of several novel thoracic aortic aneurysm genes, the involvement of the t
74                  A genetic predisposition to thoracic aortic aneurysm has been established, and gene
75                         Overall survival for thoracic aortic aneurysms has improved significantly in
76 rly experiences with endovascular grafts for thoracic aortic aneurysms have met with good to moderate
77                                     Managing thoracic aortic aneurysms identified incidentally by inc
78 patients that underwent TEVAR for descending thoracic aortic aneurysm in the MOTHER database and 231
79 ort the hypothesis that FBN1 mutations cause thoracic aortic aneurysms in patients who do not have th
80 trophy is thought to be a cause of ascending thoracic aortic aneurysms in the elderly.
81                                              Thoracic aortic aneurysm is a potentially life-threateni
82                 Although a virulent disease, thoracic aortic aneurysm is an indolent process.
83                       The risk of developing thoracic aortic aneurysm is increased more than 17-fold
84  modern understanding of the pathogenesis of thoracic aortic aneurysm is quite limited.
85 including both abdominal aortic aneurysm and thoracic aortic aneurysm, is the cause of death of 1% to
86  of the SMC contractile unit, cause familial thoracic aortic aneurysms leading to acute aortic dissec
87 redisposition for progressive enlargement of thoracic aortic aneurysms leading to type A dissection (
88 ellular remodeling of the media in ascending thoracic aortic aneurysms may be an initial adaptive res
89  an unspecified site, which may include some thoracic aortic aneurysms, may have underestimated the t
90 mputed tomographic angiography of descending thoracic aortic aneurysms (n=10 total, 5 fusiform and 5
91            Up to 20% of individuals who have thoracic aortic aneurysms or acute aortic dissections bu
92  had any significant effect on AngII-induced thoracic aortic aneurysms or atherosclerosis.
93 ted the hypothesis that FBN1 mutations cause thoracic aortic aneurysms or dissections in patients who
94 cation of individuals at risk for developing thoracic aortic aneurysms or dissections.
95                          Ruptured descending thoracic aortic aneurysm (rDTAA) is a life-threatening d
96 ach for the treatment of ruptured descending thoracic aortic aneurysms (rDTAA).
97       DHCA has been implemented in ascending thoracic aortic aneurysm resection whenever the anatomy
98 This study examined trends in mortality from thoracic aortic aneurysm (TAA) and aortic dissection (AD
99 n aortic collagen and elastin content during thoracic aortic aneurysm (TAA) development in a murine m
100 Mutations in fibrillin-1 are associated with thoracic aortic aneurysm (TAA) in Marfan syndrome.
101                                              Thoracic aortic aneurysm (TAA) is a common progressive d
102 issection (AoD) is a serious complication of thoracic aortic aneurysm (TAA).
103            Genetic aortopathy (GA) underlies thoracic aortic aneurysms (TAA) in younger adults.
104 N) with 7247 (65%) nonruptured, degenerative thoracic aortic aneurysms (TAA), 2701 (24%) descending a
105 ng-term survival of patients with descending thoracic aortic aneurysms (TAAs) after open and endovasc
106                                              Thoracic aortic aneurysms (TAAs) and valvular insufficie
107                                              Thoracic aortic aneurysms (TAAs) are common, but experim
108                                              Thoracic aortic aneurysms (TAAs) develop secondary to ab
109                                 The cause of thoracic aortic aneurysms (TAAs) is poorly understood.
110 Marfan syndrome and other forms of inherited thoracic aortic aneurysm taking CCBs display increased r
111 ACTA2, are the most common cause of familial thoracic aortic aneurysms that lead to dissection (TAAD)
112          From 1992 to 1996, 85 patients with thoracic aortic aneurysm underwent stent-graft placement
113 amily with autosomal-dominant inheritance of thoracic aortic aneurysms variably associated with the b
114  areas per examination was 1.6 (18 of 11) in thoracic aortic aneurysms versus 0.25 (14 of 57) in abdo
115 genes known to be associated with BAV and/or thoracic aortic aneurysm was performed.
116 l ascending thoracic aortas and 29 ascending thoracic aortic aneurysms was performed by directly meas
117 which men are affected predominately, 51% of thoracic aortic aneurysms were identified in women who w
118                                              Thoracic aortic aneurysms were significantly more likely
119 by use of genomic DNA from two patients with thoracic aortic aneurysms who did not have the Marfan sy

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top